King Luther Capital Management Corp Catalent, Inc. Transaction History

King Luther Capital Management Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$72.36 - $113.1 $112,158 - $175,305	-1,550 Reduced 17.06%	7,538 $545,000
Q2 2022 Aug 11, 2022	SELL	$87.2 - $114.05 $1.45 Million - $1.89 Million	-16,597 Reduced 64.62%	9,088 $975,000
Q1 2022 May 11, 2022	BUY	$94.19 - $124.49 $1.83 Million - $2.42 Million	19,413 Added 309.52%	25,685 $2.85 Million
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $749,943 - $872,247	6,272 New	6,272 $803,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on King Luther Capital Management Corp with notifications on news.